Tectonic Therapeutic, Inc.'s stock surged 120% on positive Phase 1b data for TX45 in treating PH-HFpEF, offering a potential ...

Am J Health Syst Pharm. 2010;67(5):351-360. In the ESCAPE-1 trial, which assessed clevidipine's preoperative antihypertensive effects, the types and rates of adverse effects were similar for each ...